Chinese drug developer Antengene wins backing from the likes of Boyu Capital and FountainVest Partners for a pipeline of treatments that address the country's growing cancer problem
Despite being the world’s second-largest pharmaceutical market, China isn’t known for its prowess in drug innovation. The country has some of the highest incidence rates for cancer, diabetes and liver...
Manila-based private equity firm Navegar has closed its second Philippines fund with $197 million in commitments. The initial target was $150 million.
Singapore-headquartered investment firm Blue Ashva Capital has secured a first close of INR4.5 billion ($60 million) for an India-domiciled fund that will invest in small and medium-sized enterprises (SMEs) and start-ups.
Investcorp has led a $56 million Series C round for Indian managed co-living accommodation platform operator Zolo.
Energy giant BP has agreed to invest $70 million in Green Growth Equity Fund (GGEF), a PE vehicle co-managed by Everstone Group that invests in sustainable infrastructure projects in India.